Maxime studied engineering 2005-2010 at the Faculty of Applied Sciences, Université Libre de Bruxelles (ULB) and specialised in medical informatics and imagery. He then embarked on a PhD in computational biology with Vincent Detours at the Faculty of Medicine (ULB) from 2010-2015, during which he integrated multiple omics profiles of thyroid cancers. He joined Peter Van Loo's group at the Crick early 2016 and studied intratumour heterogeneity across cancer types in light of cancer evolution, with a focus on rare sarcomas. He was also a visiting scientist at the Wellcome Trust Sanger Institute in the lab of Thierry Voet, where he developed expertise in single-cell sequencing. He is now a Junior Group Leader at IRIBHM and a visiting scientist at the Crick.